Literature DB >> 8413220

Characterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene products.

J X Lin1, N K Bhat, S John, W S Queale, W J Leonard.   

Abstract

The interleukin-2 receptor (IL-2R) beta chain (IL-2R beta) is an essential signaling component of high- and intermediate-affinity IL-2Rs. Our laboratory previously reported that a DNA fragment containing 857 bp of 5'-flanking sequence of the human IL-2R beta gene exhibited promoter activity. We have now further characterized the promoter and delineated cis-acting regulatory regions. The region downstream of -363 is critical for basal and phorbol myristate acetate-inducible IL-2R beta promoter activity and contains at least three enhancer-like regions. Among them, the -56 to -34 enhancer was the most potent and had high-level activity in two T-cell lines but not in nonlymphoid HeLaS3 and MG63 cells. This enhancer contains a GGAA Ets binding site which bound two Ets family proteins, Ets-1 and GA-binding protein in vitro. Mutation of the Ets motif strongly diminished both promoter and enhancer activities. We conclude that this Ets binding site plays a key role in regulating basal and phorbol myristate acetate-inducible IL-2R beta promoter activity and may also contribute to tissue-specific expression of the IL-2R beta gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413220      PMCID: PMC364679          DOI: 10.1128/mcb.13.10.6201-6210.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer.

Authors:  I C Ho; N K Bhat; L R Gottschalk; T Lindsten; C B Thompson; T S Papas; J M Leiden
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

2.  The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.

Authors:  F D Karim; L D Urness; C S Thummel; M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki; C V Gunther; J A Nye
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

3.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.

Authors:  B Wasylyk; C Wasylyk; P Flores; A Begue; D Leprince; D Stehelin
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

4.  The human interleukin-2 receptor beta-chain gene: genomic organization, promoter analysis and chromosomal assignment.

Authors:  H Shibuya; M Yoneyama; Y Nakamura; H Harada; M Hatakeyama; S Minamoto; T Kono; T Doi; R White; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

5.  Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.

Authors:  N K Bhat; C B Thompson; T Lindsten; C H June; S Fujiwara; S Koizumi; R J Fisher; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins.

Authors:  T A Brown; S L McKnight
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

9.  Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex.

Authors:  C C Thompson; T A Brown; S L McKnight
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

10.  The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1.

Authors:  R Bosselut; J F Duvall; A Gégonne; M Bailly; A Hémar; J Brady; J Ghysdael
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  16 in total

1.  Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.

Authors:  M Nielsen; K Kaltoft; M Nordahl; C Röpke; C Geisler; T Mustelin; P Dobson; A Svejgaard; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

2.  Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.

Authors:  S John; R B Reeves; J X Lin; R Child; J M Leiden; C B Thompson; W J Leonard
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

3.  GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction.

Authors:  A Avots; A Hoffmeyer; E Flory; A Cimanis; U R Rapp; E Serfling
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity.

Authors:  Zheng Wu; Hyoung-Pyo Kim; Hai-Hui Xue; Hong Liu; Keji Zhao; Warren J Leonard
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

5.  The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus.

Authors:  Stéphanie Eyquem; Karine Chemin; Magali Fasseu; Jean-Christophe Bories
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-20       Impact factor: 11.205

6.  GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes.

Authors:  N Bannert; A Avots; M Baier; E Serfling; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  IP3 receptor-mediated Ca2+ release in naive CD4 T cells dictates their cytokine program.

Authors:  Viswas K Nagaleekar; Sean A Diehl; Ignacio Juncadella; Colette Charland; Natarajan Muthusamy; Sheri Eaton; Laura Haynes; Lee Ann Garrett-Sinha; Juan Anguita; Mercedes Rincón
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 8.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

9.  Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients.

Authors:  Chun Fu Zheng; Gareth J Jones; Meiqing Shi; Jeremy C D Wiseman; Kaleb J Marr; Byron M Berenger; Shaunna M Huston; M John Gill; Alan M Krensky; Paul Kubes; Christopher H Mody
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells.

Authors:  Hilary R Keller; Hye Kyung Kim; Yuna Jo; Ronald E Gress; Changwan Hong; Jung-Hyun Park
Journal:  J Immunol       Date:  2020-05-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.